Cargando…

Porphyria cutanea tarda increases risk of hepatocellular carcinoma and premature death: a nationwide cohort study

BACKGROUND: Porphyria cutanea tarda (PCT) is a skin disorder originating from a deficit of the liver enzyme uroporphyrinogen decarboxylase. PCT may be a risk factor for hepatocellular carcinoma (HCC) and other cancers, but the evidence is unclear. We aimed to investigate cancer and premature mortali...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baravelli, Carl Michael, Sandberg, Sverre, Aarsand, Aasne Karine, Tollånes, Mette Christophersen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6448269/ https://www.ncbi.nlm.nih.gov/pubmed/30944007 http://dx.doi.org/10.1186/s13023-019-1051-3

Ejemplares similares

Porphyria cutanea tarda and patterns of long-term sick leave and disability pension: a 24-year nationwide matched-cohort study
por: Baravelli, Carl Michael, et al.
Publicado: (2022)

Correction: Porphyria cutanea tarda and patterns of long-term sick leave and disability pension: a 24-year nationwide matched-cohort study
por: Baravelli, Carl Michael, et al.
Publicado: (2022)

Sick leave, disability, and mortality in acute hepatic porphyria: a nationwide cohort study
por: Baravelli, Carl Michael, et al.
Publicado: (2020)

Excess risk of adverse pregnancy outcomes in women with porphyria: a population-based cohort study
por: Tollånes, Mette Christophersen, et al.
Publicado: (2010)

Health-related quality of life in porphyria cutanea tarda: a cross-sectional registry based study
por: Andersen, Janice, et al.
Publicado: (2020)

Porphyria cutanea tarda and Sjogren's syndrome()
por: Fang, Su, et al.
Publicado: (2014)

Porphyria cutanea tarda: a case report
por: Usta Atmaca, Hanife, et al.
Publicado: (2019)

Scleral Compromise in Hereditary Porphyria Cutanea Tarda
por: Paez Soria, Eugenia Andrea, et al.
Publicado: (2021)

Porphyria Cutanea Tarda in a Patient with Myelofibrosis
por: Serrano-Ordóñez, Ana, et al.
Publicado: (2023)

Hepatitis C- and HIV-induced porphyria cutanea tarda
por: Quansah, Raphael, et al.
Publicado: (2014)

Porphyria cutanea tarda in a HIV- positive patient
por: Franzon, Valéria Aparecida Zanela, et al.
Publicado: (2016)

Sporadic Porphyria Cutanea Tarda Induced by Alcohol Abuse
por: Yang, Xiu-Min, et al.
Publicado: (2017)

Porphyria Cutanea Tarda Associated With Acute Hemorrhagic Pancreatitis
por: Singh, Manasi, et al.
Publicado: (2019)

Re: Porphyria Cutanea Tarda in a Patient with Myelofibrosis
por: dos Santos, Vitorino M., et al.
Publicado: (2023)

Establishing a network of specialist Porphyria centres - effects on diagnostic activities and services
por: Tollånes, Mette C, et al.
Publicado: (2012)

Porphyria Cutanea Tarda with Constrictive Pericarditis: A Rare Association
por: Jasleen, Kaur, et al.
Publicado: (2012)

Porphyria Cutanea Tarda Presenting with Scleroderma, Ichthyosis, Alopecia, and Vitiligo
por: MacGillivray, Megan E., et al.
Publicado: (2018)

Sporadic Porphyria Cutanea Tarda as the Initial Manifestation of Hereditary Hemochromatosis
por: Edwards, Mitchell V., et al.
Publicado: (2019)

Self-efficacy and self-management strategies in acute intermittent porphyria
por: Hammersland, Marte H., et al.
Publicado: (2019)

Primary hemochromatosis presented by porphyria cutanea tarda: a case report
por: Bovenschen, H Jorn, et al.
Publicado: (2009)

Improvement in ocular cicatricial pemphigoid following treatment for porphyria cutanea tarda
por: Ford, R Marshall, et al.
Publicado: (2012)

Human Immunodeficiency Virus Associated Sporadic Nonfamilial Porphyria Cutanea Tarda
por: Guha, Sibashish Kamal, et al.
Publicado: (2016)

Case Report: Treatment of porphyria cutanea tarda with low dose hydroxychloroquine
por: Awad, Andrew, et al.
Publicado: (2022)

A Rare Case of Hereditary Hemochromatosis Presenting With Porphyria Cutanea Tarda
por: Varada, Neilmegh, et al.
Publicado: (2023)

Re-evaluation of the diagnosis of porphyria cutanea tarda in Admiral Sir Francis Beaufort
por: Peters, T J, et al.
Publicado: (2010)

Case for diagnosis. Sclerodermiform manifestations of porphyria cutanea tarda secondary to hepatitis C
por: Calado, Juliana de Oliveira Alves, et al.
Publicado: (2019)

Porphyria Cutanea Tarda Masquerading as Epidermolysis Bullosa Acquisita: A Report of Two Cases
por: Deen, Kristyn, et al.
Publicado: (2015)

Porphyria cutanea tarda unmasked by supratherapeutic estrogen during gender-affirming hormone therapy
por: Jackson Cullison, Stephanie R., et al.
Publicado: (2020)

Porphyria cutanea tarda exacerbation as a paraneoplastic syndrome in vaginal cancer resolved with chemoradiation
por: Hazell, Sarah Z., et al.
Publicado: (2020)

Ledipasvir/Sofosbuvir Is Effective as Sole Treatment of Porphyria Cutanea Tarda with Chronic Hepatitis C
por: Bonkovsky, Herbert L., et al.
Publicado: (2023)

A skin disease, a blood disease or something in between? An exploratory focus group study of patients' experiences with porphyria cutanea tarda*
por: Andersen, J, et al.
Publicado: (2015)

Porphyria cutanea tarda in a human immunodeficiency virus-infected patient: A rare scenario in India
por: Bhat, Ramesh M., et al.
Publicado: (2014)

Early presentation of adult-onset conditions: A dual diagnosis of hereditary hemochromatosis and porphyria cutanea tarda
por: Strong, Alanna, et al.
Publicado: (2020)

Secondary hemosiderosis presented by porphyria cutanea tarda in a kidney dialysis patient: A case report
por: AlGahtani, Farjah H, et al.
Publicado: (2020)

Control of porphyria cutanea tarda with anti-IL-17 secukinumab in a person with psoriasis living with HIV
por: Bedier, Helbies, et al.
Publicado: (2023)

Precipitating factors of porphyria cutanea tarda in Brazil with emphasis on hemochromatosis gene (HFE) mutations. Study of 60 patients*
por: Vieira, Fatima Mendonça Jorge, et al.
Publicado: (2013)

The D519G Polymorphism of Glyceronephosphate O-Acyltransferase Is a Risk Factor for Familial Porphyria Cutanea Tarda
por: Farrell, Colin P., et al.
Publicado: (2016)

Acute Intermittent Porphyria: An Overview of Therapy Developments and Future Perspectives Focusing on Stabilisation of HMBS and Proteostasis Regulators
por: Bustad, Helene J., et al.
Publicado: (2021)

Role of ABCB1 and glutathione S-transferase gene variants in the association of porphyria cutanea tarda and human immunodeficiency virus infection
por: Pagnotta, Priscila Ayelén, et al.
Publicado: (2021)

Porphyria cutanea tarda associated with HFE C282Y homozygosity, iron overload, and use of a contraceptive vaginal ring
por: Barton, James C., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_me32chh8gb28p67nij99dgg6on